Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 8 - Number 1




The HIV-1 Rev Binding Family of Proteins: The Dog Proteins as a Study Model

, 8(1): 30 - 46

Maria A. Panaro, Vincenzo Mitolo, Antonia Cianciulli, Pasqua Cavallo, Carlo I. Mitolo and Angela Acquafredda


DOI: 10.2174/187153008783928325





Epithelial-Mesenchymal Transition as a Therapeutic Target for Prevention of Ocular Tissue Fibrosis

, 8(1): 69 - 76

Shizuya Saika, Osamu Yamanaka, Kathleen C. Flanders, Yuka Okada, Takeshi Miyamoto, Takayoshi Sumioka, Kumi Shirai, Ai Kitano, Ken-ichi Miyazaki, Sai-ichi Tanaka and Kazuo Ikeda


DOI: 10.2174/187153008783928343




Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog